Table 1.
Table of studies involving emergent laparoscopic colorectal surgery and inflammatory bowel disease
| Ref. | Type of study | Number of LCS patients | Institution | Main outcome |
| Nash et al[27] | Comparative | 36 | Single | No difference in morbidity; |
| Longer operating time in LCS; | ||||
| Shorter hospital stay | ||||
| Stulberg et al[14] | Comparative | 42 | Single-centre | Less blood loss, shorter stay, less morbidity |
| Marceau et al[26] | Comparative | 40 | Single-centre | Similar operating time; |
| Hospital stay similar; | ||||
| Morbidity similar | ||||
| Fowkes et al[21] | Comparative | 22 | Single centre | Shorter hospital stay; |
| Similar morbidity | ||||
| Seshadri et al[28] | Comparative | 37 | Single-centre | Longer operating time in LCS; |
| No differences in complications; | ||||
| Less post-op morbidity; | ||||
| Shorter hospital stay | ||||
| Watanabe et al[29] | Comparative | 30 | Single-centre | Longer operating time in LCS; |
| Fewer post-op complications in LCS; | ||||
| Faster gut recovery in LCS | ||||
| Qazi et al[24] | Comparative | 17 | Single-centre | Increased complications in LCS; |
| Conversion rate of 32% | ||||
| Marcello et al[6] | Comparative | 16 | Single-centre | Early oral intake in LCS; |
| No difference in morbidity | ||||
| Ouaïssi et al[25] | Single cohort | 18 | Single-centre | Safe; feasible; |
| Morbidity 33% | ||||
| Bell and Seymour[31] | Single cohort | 18 | Single-centre | High morbidity; |
| Shorter hospital stay |
LCS: Laparoscopic colorectal surgery.